1. Home
  2. ATHA vs PASW Comparison

ATHA vs PASW Comparison

Compare ATHA & PASW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • PASW
  • Stock Information
  • Founded
  • ATHA 2011
  • PASW 2021
  • Country
  • ATHA United States
  • PASW Hong Kong
  • Employees
  • ATHA N/A
  • PASW N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • PASW Apparel
  • Sector
  • ATHA Health Care
  • PASW Consumer Discretionary
  • Exchange
  • ATHA Nasdaq
  • PASW Nasdaq
  • Market Cap
  • ATHA 16.1M
  • PASW 15.9M
  • IPO Year
  • ATHA 2020
  • PASW N/A
  • Fundamental
  • Price
  • ATHA $4.11
  • PASW $0.60
  • Analyst Decision
  • ATHA
  • PASW
  • Analyst Count
  • ATHA 0
  • PASW 0
  • Target Price
  • ATHA N/A
  • PASW N/A
  • AVG Volume (30 Days)
  • ATHA 27.3K
  • PASW 117.1K
  • Earning Date
  • ATHA 11-06-2025
  • PASW 01-12-2026
  • Dividend Yield
  • ATHA N/A
  • PASW N/A
  • EPS Growth
  • ATHA N/A
  • PASW N/A
  • EPS
  • ATHA N/A
  • PASW N/A
  • Revenue
  • ATHA N/A
  • PASW $8,286,193.00
  • Revenue This Year
  • ATHA N/A
  • PASW N/A
  • Revenue Next Year
  • ATHA N/A
  • PASW N/A
  • P/E Ratio
  • ATHA N/A
  • PASW N/A
  • Revenue Growth
  • ATHA N/A
  • PASW N/A
  • 52 Week Low
  • ATHA $2.20
  • PASW $0.59
  • 52 Week High
  • ATHA $8.26
  • PASW $5.40
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 59.40
  • PASW N/A
  • Support Level
  • ATHA $3.95
  • PASW N/A
  • Resistance Level
  • ATHA $4.50
  • PASW N/A
  • Average True Range (ATR)
  • ATHA 0.24
  • PASW 0.00
  • MACD
  • ATHA -0.05
  • PASW 0.00
  • Stochastic Oscillator
  • ATHA 55.81
  • PASW 0.00

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

Share on Social Networks: